A part of Merck

Viresolve® NFR Filters

Viresolve® NFR filters with Retropore® membrane quickly and efficiently remove retroviruses from recombinant protein solutions or human plasma sources.



Información para pedidos

Viresolve NFR Filters Borrar Clasificación y Filtrado
Número de referenciaicon Descripciónicon Longitud nominal del cartuchoicon Volumen de procesoicon Código del cartuchoicon Tamaño de envaseicon
CZRV71TP1Viresolve NFR 10 pulg. (25 cm), código 7 10 in. (25 cm) 600 L–1200 L Code 7 1 Precios y disponibilidad
CZRV72TP1Viresolve NFR 20 pulg. (50 cm), código 7 20 in. (50 cm) 1200 L–2400 L Code 7 1 Precios y disponibilidad
CZRV73TP1Viresolve NFR 30 pulg. (75 cm), código 7 30 in. (75 cm) 1800 L–3600 L Code 7 1 Precios y disponibilidad

Volver al principio


    Licencias necesarias e Información técnica

    Application Note - Ensuring Compliance: Regulatory guidance for virus clearance validation
    The Vmax Nomograph Reference tool for Filter Sizing

    Ficha técnica

    Provantage™ Services - Viral Clearance Validation Services
    Viresolve® NFR Filters

    Referencias bibliográficas

    Visión general referencias
    Validation of Virus Filtration
    Carter, Jeff and Herb Lutz
    BioProcess International January 2003: 52-62 2003

    Performance of a novel viresolve NFR virus filter.
    Brough Helene; Antoniou Chris; Carter Jeffrey; Jakubik Jocelyn; Xu Yuan; Lutz Herbert
    Biotechnology Progress 18 (4):p782-795 July-August, 2002 2002

    Mostrar resumen
    Removal of prion challenge from an immune globulin preparation by use of a size-exclusion filter
    VAN HOLTEN Robert W; AUTENRIETH Stephen; BOOSE Jeri Ann; HSIEH W T; DOLAN Sherri
    Transfusion : (Philadelphia, PA), 2002, 42 (8) 999-1004 2002

    An overview of viral filtration in biopharmaceutical manufacturing
    Jeffrey Carter and Herbert Lutz, Millipore Corporation, Bedford, MA, USA; European Journal of Parenteral Sciences 2002; 7(3): 72–78 © 2002 Parenteral Society
    European Journal of Parenteral Sciences 2002; 7(3): 72–78 © 2002 Parenteral Society 2002

    Development and Qualification of a Novel Virus Removal Filter for Cell Culture Applications
    Shengjiang Liu, Mark Carroll, Raquel Iverson, Christine Valera, Joann Vennari, Kimberly Turco, Robert Piper, Robert Kiss, Herbert Lutz
    Biotechnology Progress 2000

    Filtration and the Removal of Viruses from Biopharmaceuticals
    Levy, Richard V., Michael W. Phillips, and Herbert Lutz
    Chapter 20 in Filtration in the Biopharmaceutical Industry. New York: Marcel Dekker, Inc., 1998. 1998

    A Validatible Porosimetric Technique for Verifying the Integrity of Virus-Retentive Membranes
    Michael W. Phillips and Anthony J. DiLeo Advanced Separations Research Department, Millipore Corporation, 80 Ashby Road, Bedford MA 0 1 730, U.S.A.
    Biologicals. 1996 Sep;24(3):243-53. 1996

    High Resolution Removal of Virus From Protein Solutions Using A Membrane of Unique Structure
    DiLeo, Anthony J., Anthony E. Allegrezza, and Stuart E. Builder
    Bio/Technology (February 1992): 182-188; RP002 1992

    Manuales del usuario

    Viresolve® NFR Filters

    Productos y aplicaciones relacionados

    Familias de productos

    Productos relacionados por: Application Facete

    Productos relacionados por: Brand Facete


    Biopharmaceutical Manufacturing > Downstream Processing > Virus Safety > Virus Filtration > Viresolve Pro & Pro+ > Viresolve NFR